NTRA Q2 2018 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena

NTRANatera, Inc.

$28B

Q2 2018 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$63M+17.6% YoY

Gross Profit

$22M35.0% margin

Operating Income

-$27M-43.2% margin

Net Income

-$34M-53.6% margin

EPS (Diluted)

$-0.62

QoQ Revenue Growth

+1.2%

Cash Flow

Operating Cash Flow

-$36M

Free Cash Flow

-$36M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$194M

Total Liabilities

$216M

Stockholders' Equity

-$22M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$63M	$54M	+17.6%
Gross Profit	$22M	$19M	+15.8%
Operating Income	-$27M	-$27M	-0.7%
Net Income	-$34M	-$28M	-22.0%

Revenue Segments

Product

$60M48%

Panorama Nipt

$36M28%

Hcs

$21M17%

Other Genetic Tests

$3M3%

Licensing And Other

$3M2%

Other Licensing And Other

$1M1%

Constellation

$1M1%

Geographic Segments

U

$57M90%

E M E A

$4M6%

X

$2M3%

Americas Excluding Us

$847,0001%